2024-09-16 - Analysis Report
## Verily Life Sciences Holdings Inc. (VRTX) Stock Analysis

**Company Overview:** Verily Life Sciences Holdings Inc. is a healthcare technology company focused on developing and deploying technology-driven solutions to improve healthcare outcomes.

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**
* **Cumulative Return:** VRTX (113.82%) outperformed VOO (88.73%) by 25.09%.
* **Relative Divergence:**  The current relative divergence is 81.01%, indicating that VRTX has been performing better than VOO over the past period, but not at its absolute peak. 

**2. Recent Price Movements:**
* **Closing Price:** $485.37
* **5-Day Moving Average:** $476.13
* **20-Day Moving Average:** $480.67
* **60-Day Moving Average:** $481.40
* **Analysis:**  VRTX is trading slightly above its 5-day, 20-day, and 60-day moving averages, suggesting short-term bullish momentum.

**3. Technical Indicators:**
* **RSI:** 52.91 (Neutral)
* **PPO:** 0.02 (Slightly Positive)
* **Delta_Previous_Relative_Divergence:** 2.03 (Positive, indicating short-term upward momentum)
* **Expected Return:** 9.21% (Maximum 5-year expected return based on current investment amount)

**4. Recent Earnings and Outlook:**
* **Earnings:**
    * **Date | EPS | Revenue**
    * **2024-08-02 | -13.92 | 2.65 B$** 
    * **2024-05-07 | 4.26 | 2.69 B$**
    * **2023-11-07 | 4.01 | 2.48 B$**
    * **2023-08-02 | 3.55 | 2.49 B$**
    * **2024-08-02 | 3.55 | 2.49 B$**

* **Analysis:** The most recent earnings report for Q2 2024 showed a significant decline in EPS compared to previous quarters. While revenue remained relatively consistent, the negative earnings are a cause for concern. Analysts will be closely watching upcoming earnings reports to assess if this is a trend or a one-off event.

**5. Summary:**

* **Performance:** VRTX has been performing well compared to the overall market, exceeding the S&P 500's performance by a significant margin.
* **Price Action:** Recent price movements indicate short-term bullish momentum. 
* **Technical Indicators:** Technical indicators suggest neutral to slightly positive sentiment with short-term upward momentum.
* **Earnings:** The most recent earnings report showed a significant drop in EPS, which is a cause for concern and warrants close monitoring in future reports.

**Overall:**

Verily Life Sciences Holdings Inc. (VRTX) exhibits a promising performance record compared to the broader market. However, the recent earnings report raises some concerns about the company's future profitability. It is important to carefully monitor upcoming earnings reports and other key developments to make an informed investment decision. 
